Letter to the editor regarding “Robotic and navigated pedicle screws are safer and more accurate than fluoroscopic freehand screws: a systematic review and meta-analysis” by Matur et al.

TY - JOUR

T1 - Letter to the editor regarding “Robotic and navigated pedicle screws are safer and more accurate than fluoroscopic freehand screws

T2 - a systematic review and meta-analysis” by Matur et al.

AU - Greenberg, Jacob K.

AU - Pelle, Dominic

AU - Clifton, William

AU - Javeed, Saad

AU - Ray, Wilson Z.

AU - Kelly, Michael P.

AU - Wang, Jeffrey C.

AU - Harrop, James S.

AU - Vaccaro, Alexander R.

AU - Ghogawala, Zoher

AU - Savage, Jason W.

AU - Steinmetz, Michael P.

N1 - Funding Information: Author disclosures: JKG: Nothing to disclose. DP: Consulting: Stryker (C), Globus (C). WC : Royalties: Symgery; Consulting: Bard; Scientific Advisory Board: Bard (B). SJ: Nothing to disclose. WZR: Royalties: Acera Surgical (D); Consulting: Nuvasive (A), Corelink (B), Depuy (C), Globus (C); Grants: Department of Defense, NIH (Paid directly to institution); Fellowship Support: NREF (Paid directly to institution), Medtronic (Paid directly to institution). MPK: Consulting fee or honorarium: Wolters Kluwer (B, Paid directly to institution). JCW: Royalties: Zimmer Biomet (F), Seaspine (C), Depuy Synthes (B), Novapproach (A); Stock Ownership: Bone Biologics, Pearldiver, electrocore, surgitech; Consulting: Bioretec, Angitia, Epidutech; Board of Directors: AO Foundation (B); Fellowship Support: AO Spine North America (E, Paid directly to institution). JSH: Nothing to disclose. ARV: Royalties: Stryker (G), Globus (D), Medtronic (F), Atlas (B), Alphatech Spine (F), Elsevier (A), Jaypee (A), Taylor Francis/Hodder and Stoughton (A), Thieme (B); Stock Ownership: Accelus (100,000 shares), Advanced Spinal Intellectual Properties (Unknown number of options, 29% ownership), Atlas (25,000 shares), Avaz Surgical (277 shares), AVKN Patient Driven Care (Unknown number of options, 50% ownership), Bonovo Orthopaedics (100,000 shares), Computational Biodynamics (Unknown number of options, 25% ownership), Cytonics (25,000 shares), Deep Health (830 shares), Dimension Orthotics LLC (Unknown number of options, 20.62% ownership), Electrocore (38,439 shares), Flagship Surgical (50,000 shares), FlowPharma (200,000 shares), Globus (123,398 shares), Harvard MedTech (20,000 shares), Innovative Surgical Design (35,484 shares), Jushi (Haywood) (135,980 shares), Nuvasive (30,000 shares), Orthobullets (30,000 shares), Parvizi Surgical Innovation (100,000 shares), Progressive Spinal Technologies (Unknown number of options, 14.5% ownership), Replication Medica (15,000 shares), Sentryx (40,000 shares), Spineology (8,125 shares), Stout Medical (561 shares), ViewFi Health (5,000 shares); Consulting: Globus (B). ZG: Nothing to disclose. JWS: Consulting: Stryker Spine (E). MPS: Royalties: Elselvier, NASS (Deputy Editor, The Spine Journal) (B), Globus (A), Biomet (B); Consulting: Globus (B); Speaking and/or Teaching Arrangements: Globus (B), Premia Spine (B); Board of Directors (Past Chair); Neuropoint alliance (non compensated); Scientific Advisory Board: CeraPedics (B). Funding Information: This work did not receive any funding. Author disclosures: JKG: Nothing to disclose. DP: Consulting: Stryker (C), Globus (C). WC: Royalties: Symgery; Consulting: Bard; Scientific Advisory Board: Bard (B). SJ: Nothing to disclose. WZR: Royalties: Acera Surgical (D); Consulting: Nuvasive (A), Corelink (B), Depuy (C), Globus (C); Grants: Department of Defense, NIH (Paid directly to institution); Fellowship Support: NREF (Paid directly to institution), Medtronic (Paid directly to institution). MPK: Consulting fee or honorarium: Wolters Kluwer (B, Paid directly to institution). JCW: Royalties: Zimmer Biomet (F), Seaspine (C), Depuy Synthes (B), Novapproach (A); Stock Ownership: Bone Biologics, Pearldiver, electrocore, surgitech; Consulting: Bioretec, Angitia, Epidutech; Board of Directors: AO Foundation (B); Fellowship Support: AO Spine North America (E, Paid directly to institution). JSH: Nothing to disclose. ARV: Royalties: Stryker (G), Globus (D), Medtronic (F), Atlas (B), Alphatech Spine (F), Elsevier (A), Jaypee (A), Taylor Francis/Hodder and Stoughton (A), Thieme (B); Stock Ownership: Accelus (100,000 shares), Advanced Spinal Intellectual Properties (Unknown number of options, 29% ownership), Atlas (25,000 shares), Avaz Surgical (277 shares), AVKN Patient Driven Care (Unknown number of options, 50% ownership), Bonovo Orthopaedics (100,000 shares), Computational Biodynamics (Unknown number of options, 25% ownership), Cytonics (25,000 shares), Deep Health (830 shares), Dimension Orthotics LLC (Unknown number of options, 20.62% ownership), Electrocore (38,439 shares), Flagship Surgical (50,000 shares), FlowPharma (200,000 shares), Globus (123,398 shares), Harvard MedTech (20,000 shares), Innovative Surgical Design (35,484 shares), Jushi (Haywood) (135,980 shares), Nuvasive (30,000 shares), Orthobullets (30,000 shares), Parvizi Surgical Innovation (100,000 shares), Progressive Spinal Technologies (Unknown number of options, 14.5% ownership), Replication Medica (15,000 shares), Sentryx (40,000 shares), Spineology (8,125 shares), Stout Medical (561 shares), ViewFi Health (5,000 shares); Consulting: Globus (B). ZG: Nothing to disclose. JWS: Consulting: Stryker Spine (E). MPS: Royalties: Elselvier, NASS (Deputy Editor, The Spine Journal) (B), Globus (A), Biomet (B); Consulting: Globus (B); Speaking and/or Teaching Arrangements: Globus (B), Premia Spine (B); Board of Directors (Past Chair); Neuropoint alliance (non compensated); Scientific Advisory Board: CeraPedics (B).

PY - 2023/8

Y1 - 2023/8

UR - http://www.scopus.com/inward/record.url?scp=85164977607&partnerID=8YFLogxK

U2 - 10.1016/j.spinee.2023.04.008

DO - 10.1016/j.spinee.2023.04.008

M3 - Letter

C2 - 37084821

AN - SCOPUS:85164977607

SN - 1529-9430

VL - 23

SP - 1234

EP - 1235

JO - Spine Journal

JF - Spine Journal

IS - 8

ER -